Federal Reserve Economic Data

Quarterly Financial Report: U.S. Corporations: Pharmaceuticals and Medicines: All Other Noncurrent Assets (QFRD222385USNO)

Observation:

Q2 2024: 1,254,666 (+ more)   Updated: Sep 10, 2024 9:09 AM CDT
Q2 2024:  1,254,666  
Q1 2024:  1,261,438  
Q4 2023:  1,243,762  
Q3 2023:  1,165,418  
Q2 2023:  1,173,773  
View All

Units:

Millions of Dollars,
Not Seasonally Adjusted

Frequency:

Quarterly

NOTES

Source: U.S. Census Bureau  

Release: Quarterly Financial Report  

Units:  Millions of Dollars, Not Seasonally Adjusted

Frequency:  Quarterly

Notes:

Further information related to the Quarterly Financial Report survey can be found at https://www.census.gov/econ/qfr/about.html
Methodology details can be found at https://www.census.gov/econ/qfr/documents/QFR_Methodology.pdf

Suggested Citation:

U.S. Census Bureau, Quarterly Financial Report: U.S. Corporations: Pharmaceuticals and Medicines: All Other Noncurrent Assets [QFRD222385USNO], retrieved from FRED, Federal Reserve Bank of St. Louis; https://fred.stlouisfed.org/series/QFRD222385USNO, .


Subscribe to the FRED newsletter


Follow us

Back to Top
Top